NovaBridge Biosciences Says FDA Grants Fast Track Designation To Givastomig In First-Line HER2-Negative Metastatic Gastric Cancer
NovaBridge Biosciences NBP
$1.52
▼ -3.18%
($-0.05)
Open
$1.59
Prev Close
$1.57
Day Range
$1.48 – $1.62
52W Range
$1.46 – $6.79
Market Cap
$173.07M
Beta
1.49
EPS (TTM)
$-0.19
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2020-01-17 |
| Shares Out. | 265,990,000 |
| Website | novabridge.com/ ↗ |
| Phone | 13016702800 |
NovaBridge Biosciences is a publicly traded company under the ticker symbol NBP on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
9 analysts (2026-06-01)